Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Phase 1 study results of selinexor combination therapy; multiple myeloma

Science Daily - 6 Jun 2016 22:28
Researchers have completed a phase 1 study of selinexor in combination with liposomal doxorubicin and dexamethasone in patients with relapsed and refractory multiple myeloma.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard